TBPH 9.97 (+0.5%)
KYG8807B1068BiotechnologyBiotechnology

Theravance Biopharma (TBPH) Stock Highlights

9.97 | +0.5%
2024-11-21 04:44:17
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. It develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Statistics

Range Today
9.71 10.1
Volume Today 352.8K
Range 1 Year
7.44 11.71
Volume 1 Year 88.64M
Range 3 Year
7.44 13.17
Volume 3 Year 449.52M
Range 10 Year
6.1 43.44
Volume 10 Year 1.02B

Highlights

Market Capitalization 437.36M (small)
Floating Shares 21.17M
Current Price 9.97
Price To Earnings -9.21
Price To Revenue 6.25
Price To Book 2.26
Earnings Per Share -0.95
Payout Ratio 0%

Performance

Latest +0.5%
1 Month +13.55%
3 Months +19.12%
6 Months +7.44%
1 Year -4.13%
3 Years +18.83%
5 Years -42.6%
10 Years -38.07%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.